Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 42.49 USD -0.07% Market Closed
Market Cap: 3.2B USD

Intrinsic Value

The intrinsic value of one KNSA stock under the Base Case scenario is hidden USD. Compared to the current market price of 42.49 USD, Kiniksa Pharmaceuticals Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

KNSA Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Kiniksa Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

KNSA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether KNSA usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about KNSA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is KNSA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Kiniksa Pharmaceuticals Ltd.

Explain Valuation
Compare KNSA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KNSA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kiniksa Pharmaceuticals Ltd

Current Assets 475.5m
Cash & Short-Term Investments 352.1m
Receivables 51.7m
Other Current Assets 71.7m
Non-Current Assets 236.8m
PP&E 11.7m
Intangibles 15.5m
Other Non-Current Assets 209.6m
Current Liabilities 123.6m
Accounts Payable 6.2m
Accrued Liabilities 96.9m
Other Current Liabilities 20.5m
Non-Current Liabilities 53.4m
Other Non-Current Liabilities 53.4m
Efficiency

Free Cash Flow Analysis
Kiniksa Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Kiniksa Pharmaceuticals Ltd

Revenue
598m USD
Cost of Revenue
-74.6m USD
Gross Profit
523.3m USD
Operating Expenses
-485.2m USD
Operating Income
38.2m USD
Other Expenses
-2.2m USD
Net Income
35.9m USD
Fundamental Scores

KNSA Profitability Score
Profitability Due Diligence

Kiniksa Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional Gross Margin
Positive 3Y Average ROE
Strong 3Y Average Gross Margin
hidden
Profitability
Score

Kiniksa Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

KNSA Solvency Score
Solvency Due Diligence

Kiniksa Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
hidden
Solvency
Score

Kiniksa Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KNSA Price Targets Summary
Kiniksa Pharmaceuticals Ltd

Wall Street analysts forecast KNSA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KNSA is 55.81 USD with a low forecast of 48.48 USD and a high forecast of 65.1 USD.

Lowest
Price Target
48.48 USD
14% Upside
Average
Price Target
55.81 USD
31% Upside
Highest
Price Target
65.1 USD
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Kiniksa Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for KNSA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

KNSA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one KNSA stock?

The intrinsic value of one KNSA stock under the Base Case scenario is hidden USD.

Is KNSA stock undervalued or overvalued?

Compared to the current market price of 42.49 USD, Kiniksa Pharmaceuticals Ltd is hidden .

Back to Top